

For an enterprise pharma team, one of the most valuable numbers in an AI roleplay proposal is the one that shouldn’t change.
Training budgets are set a year out. Launch dates don't move for procurement. Every scenario your reps practice has to clear MLR review before it reaches the field. A pricing model that works in that environment has to give you a number you can reliably plan around, and a team that can get your program live on your timeline.
That matters more right now, because a new kind of offer is showing up in AI roleplay evaluations: a very low per-user price, backed by usage credits and a self-serve build. It is easy to say yes to, but may have some hidden traps that aren’t actually easy to live with. This guide explains how these models work, where the cost shows up later, and what to look for in a pricing model built for enterprise life sciences.
AI roleplay has moved from experiment to budget line, and vendors are competing hard for a place in it. One way to win a seat quickly is to lead with a price that makes the decision feel trivial.
These offers tend to share three features:
Each feature makes sense in isolation. Together, they move cost, work, and burden of success from the vendor to you, and the problems associated with these approaches tend to surface after the contract is signed, when it's hardest to change course.
Usage-based pricing sounds fair: pay for what you use. In practice, it charges you more, and more aggressively, precisely when the program is working.
Consider what success looks like for an AI roleplay program. Reps practice more. Managers assign more scenarios. Certification becomes a gate before every launch. Each of those outcomes increases usage, and under a metered model, each one increases cost. The better your reps adopt the program, the more you pay. That is a tax on success.
It gets steeper in pharma for three reasons:
Unexpected charges are not an edge case. In Zylo's 2026 SaaS Management Index, 78% of IT leaders reported unexpected charges tied to consumption or AI features in the past year.
The cost also shows up in behavior. When every session has a price, someone starts rationing practice. Training teams cap assignments, reps get steered toward the cheaper mode, and a program meant to build readiness ends up managing a meter.
The second hidden cost is the build. A self-serve platform hands your team the tools and leaves the work with you.
In life sciences, the work is most of the program. Personas, objection paths, and scoring criteria have to be built from your approved content, reviewed through MLR, and calibrated against how your own trainers define good. A generic avatar and a template rubric rarely make it through review, and a scenario that can't clear review can't reach a rep.
The build doesn't end at launch either. Every label change, new indication, and new hire class creates more content to author, review, and calibrate. When that work sits with an already stretched training team, the program slows down, and the low price buys a platform that's harder to use than it looked in the demo.
A pricing model built for enterprise life sciences should do four things:
That is how Quantified prices AI Roleplay.
You get one price, scoped to your field force and the capabilities you need, and you know it at signing. Practice isn't metered and there are no overage charges. White-glove service comes standard, not something you pay extra for: our team builds your personas, scenarios, and rubrics from your approved content, calibrates scoring with your trainers, and supports you through rollout.
That model is how Sanofi certified a 500-rep force in five days with four trainers. As Chrissy Richards, Director of Commercial Training at Sanofi, put it: "It was super easy to use for the learners...the managers were able to start coaching right away."
It's also why Quantified is used by 55,000+ field reps at 30+ enterprise customers, including more than 10 of the top global pharmaceutical companies.
Our price won't be the lowest headline number in your evaluation. It will be the number you pay, for a program that's built, reviewed, and running on your timeline.
The last question is the most revealing. If the renewal price climbs with your success, the vendor has told you how the model works.
If you plan to start with a pilot, our AI roleplay pilot guide covers how to structure an evaluation that shows real results.
If your team signed for a low per-user price, watch for these signs in the first few months:
Any one of these means the true cost of the program is higher than the contract price. Map your expected usage against your launch calendar for the rest of the term, and price what's left before renewal. If the math doesn't hold, talk to us. We'll scope a program around your field force, your content, and your calendar, with one price and the services included.
Want to learn more about our pricing model? Visit our Pricing page.
It depends on the size of your field force, the capabilities in scope, and whether services are included. The useful comparison is total program cost across the full contract, including usage, scenario builds, MLR support, and renewal terms, not the headline per-user price.
Token-based pricing sells practice as a balance of credits that each session draws down, often at different rates for text, basic avatars, and realistic video avatars. It keeps the entry price low but makes total cost hard to predict, because cost rises as reps practice more and in more realistic modes.
Roleplay content in life sciences has to be built from approved materials and clear MLR review before reps can use it. Building, calibrating, and updating that content is a large share of the work in any program, so whether services are included has a major effect on total cost and time to launch.